Narasimhan Mani

Chief Executive Officer at Xiromed LLC

Health Technology

Consumer Services

Profile

Narasimhan Mani is currently the Chief Executive Officer at Xiromed LLC since 2019.
Prior to this, he worked as the Director-Global Business Development & Portfolio at Amneal Pharmaceuticals LLC.
He holds an MBA from The Trustees of Columbia University in The City of New York and a doctorate from the University of Georgia.

Narasimhan Mani active positions

Companies	Position	Start
Xiromed LLC Xiromed LLC Pharmaceuticals: MajorHealth Technology Xiromed LLC engages in bringing generic pharmaceuticals to the United States market. The firm offers products in different formats and presentations: oral, inhalation, hormonal, injectable, semisolid and soft gel. Its flagship product is Lansoprazole Delayed Release, 30 mg. The company is headquartered in Florham Park, NJ.	Chief Executive Officer	2019-01-31

All active positions of Narasimhan Mani

Former positions of Narasimhan Mani

Companies	Position	End
Amneal Pharmaceuticals LLC Amneal Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amneal Pharmaceuticals LLC manufactures and distributes generic pharmaceuticals. It offers buprenorphine and naloxone tablets, ear drops, scalp and body oils, liquid syrups, folic acid tablets and oral solids. The company was founded by Chintu Patel, Chirag K. Patel and Jiten Parikh in June 2002 and is headquartered in Bridgewater, NJ.	Corporate Officer/Principal	-

See the detail of Narasimhan Mani's experience

Training of Narasimhan Mani

The Trustees of Columbia University in The City of New York	Masters Business Admin
University of Georgia	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies